Expanded Access for Bromodomain and Extra-Terminal (BET) Inhibitor

Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia)

NCT04826172 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Determine the Effects of BXT-51072 in Diabetic Patients Undergoing Angioplasty (PCI)

NCT00320502 ·Status: COMPLETED ·Phase: PHASE2

Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance

NCT00733174 ·Status: UNKNOWN ·Phase: PHASE4

To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter

NCT00090714 ·Status: UNKNOWN ·Phase: PHASE2

Integrating Pharmacogenetics In Clinical Care

NCT02871934 ·Status: COMPLETED ·Phase: NA

Nitrites, Exercise, and Peripheral Arterial Disease

NCT01684930 ·Status: COMPLETED ·Phase: PHASE2

Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients

NCT00751608 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease

NCT00185042 ·Status: COMPLETED ·Phase: PHASE2

The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome

NCT00759291 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk

NCT02991118 ·Status: COMPLETED ·Phase: PHASE3

Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel

NCT02140801 ·Status: COMPLETED ·Phase: PHASE4

Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans

NCT04769206 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory Angina

NCT04306237 ·Status: WITHDRAWN ·Phase: PHASE2

ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes

NCT06469528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD

NCT02586155 ·Status: COMPLETED ·Phase: PHASE3

Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients

NCT00995930 ·Status: COMPLETED ·Phase: PHASE2

Inflammation and Vascular Function in Atherosclerosis

NCT00760019 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction

NCT05711719 ·Status: COMPLETED ·Phase: PHASE2

A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis

NCT00382213 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study of BNS003 on Swelling in Legs Due to Venous Reflux

NCT02211898 ·Status: COMPLETED ·Phase: PHASE3

A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis

NCT02239211 ·Status: COMPLETED ·Phase: PHASE2

Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study

NCT05263778 ·Status: UNKNOWN ·Phase: PHASE4

Carnosine for Peripheral Arterial Disease Patients

NCT05371145 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging

NCT00633022 ·Status: COMPLETED ·Phase: PHASE2

Multidisciplinary Approach to Reduce Cardiovascular Health Disparities

NCT06168968 ·Status: RECRUITING